Search results
Found 16154 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
EXTEND Newsletter: Issue 1, January 2023
Issue #1 of the quarterly newsletter for the EXTEND Study
According to EXTEND-InG
Members of the EXTEND Involvement Group on why the EXTEND project is important and why they've got involved.